Bong-Jo Kim

Bong-Jo Kim


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2020 in Nature
Verified
Journal Article
Closed access
PDF file
CSCassandra N. Spracklen
Cassandra N. Spracklen
MHMomoko Horikoshi
Momoko Horikoshi
YKYoung Jin Kim
Young Jin Kim
KLKuang Lin
Kuang Lin
FBFiona Bragg
Fiona Bragg
XSXueling Sim
Xueling Sim

4 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
YKYoung Jin Kim
Young Jin Kim
SMSanghoon Moon
Sanghoon Moon
MHMi Yeong Hwang
Mi Yeong Hwang
SHSohee Han
Sohee Han
HJHye-Mi Jang
Hye-Mi Jang
BKBong-Jo Kim
Bong-Jo Kim
Metabolic traits are heritable phenotypes widely-used in assessing the risk of various diseases. We conduct a genome-wide association analysis (GWAS) of nine metabolic traits (including glycemic, lipid, liver enzyme levels) in 125,872 Korean subjects genotyped with the Korea Biobank Array. Following meta-analysis with GWAS from Biobank Japan identify 144 novel signals (MAF ≥ 1%), of which 57.0% are replicated in UK Biobank. Additionally, we discover 66 rare (MAF < 1%) variants, 94.4% of them co-incident to common loci, adding to allelic series. Although rare variants have limited contribution to overall trait variance, these lead, in carriers, substantial loss of predictive accuracy from polygenic predictions of disease risk from common variant alone. We capture groups with up to 16-fold variation in type 2 diabetes (T2D) prevalence by integration of genetic risk scores of fasting plasma glucose and T2D and the I349F rare protective variant. This study highlights the need to consider the joint contribution of both common and rare variants on inherited risk of metabolic traits and related diseases.

29 October 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JYJun Ho Yun
Jun Ho Yun
JKJeong-Min Kim
Jeong-Min Kim
HJHyun Jeong Jeon
Hyun Jeong Jeon
TOTaekeun Oh
Taekeun Oh
HCHyung Jin Choi
Hyung Jin Choi
BKBong-Jo Kim
Bong-Jo Kim
Diabetic retinopathy (DR) is a common complication of diabetes, and it is the consequence of microvascular retinal changes due to high glucose levels over a long time. Metabolomics profiling is a rapidly evolving method used to identify the metabolites in biological fluids and investigate disease progression. In this study, we used a targeted metabolomics approach to quantify the serum metabolites in type 2 diabetes (T2D) patients. Diabetes patients were divided into three groups based on the status of their complications: non-DR (NDR, n = 143), non-proliferative DR (NPDR, n = 123), and proliferative DR (PDR, n = 51) groups. Multiple logistic regression analysis and multiple testing corrections were performed to identify the significant differences in the metabolomics profiles of the different analysis groups. The concentrations of 62 metabolites of the NDR versus DR group, 53 metabolites of the NDR versus NPDR group, and 30 metabolites of the NDR versus PDR group were found to be significantly different. Finally, sixteen metabolites were selected as specific metabolites common to NPDR and PDR. Among them, three metabolites including total DMA, tryptophan, and kynurenine were potential makers of DR progression in T2D patients. Additionally, several metabolites such as carnitines, several amino acids, and phosphatidylcholines also showed a marker potential. The metabolite signatures identified in this study will provide insight into the mechanisms underlying DR development and progression in T2D patients in future studies.

24 November 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
MHMi Yeong Hwang
Mi Yeong Hwang
NCNak-Hyeon Choi
Nak-Hyeon Choi
HWHong Hee Won
Hong Hee Won
BKBong-Jo Kim
Bong-Jo Kim
YKYoung Jin Kim
Young Jin Kim
Genotype imputation is essential for enhancing the power of association-mapping and discovering rare and indels that are missed by most genotyping arrays. Imputation analysis can be more accurate with a population-specific reference panel or a multi-ethnic reference panel with numerous samples. The National Institute of Health, Republic of Korea, initiated the Korean Reference Genome (KRG) project to identify variants in whole-genome sequences of ∼20,000 Korean participants. In the pilot phase, we analyzed the data from 1,490 participants. The genetic characteristics and imputation performance of the KRG were compared with those of the 1,000 Genomes Project Phase 3, GenomeAsia 100K Project, ChinaMAP, NARD, and TOPMed reference panels. For comparison analysis, genotype panels were artificially generated using whole-genome sequencing data from combinations of four different ancestries (Korean, Japanese, Chinese, and European) and two population-specific optimized microarrays (Korea Biobank Array and UK Biobank Array). The KRG reference panel performed best for the Korean population (R2 = 0.78–0.84, percentage of well-imputed is 91.9% for allele frequency >5%), although the other reference panels comprised a larger number of samples with genetically different background. By comparing multiple reference panels and multi-ethnic genotype panels, optimal imputation was obtained using reference panels from genetically related populations and a population-optimized microarray. Indeed, the reference panels of KRG and TOPMed showed the best performance when applied to the genotype panels of KBA (R2 = 0.84) and UKB (R2 = 0.87), respectively. Using a meta-imputation approach to merge imputation results from different reference panels increased the imputation accuracy for rare variants (∼7%) and provided additional well-imputed variants (∼20%) with comparable imputation accuracy to that of the KRG. Our results demonstrate the importance of using a population-specific reference panel and meta-imputation to assess a substantial number of accurately imputed rare variants.

21 July 2016 in Journal of Human Genetics
Verified
Journal Article
Closed access
MGMin Jin Go
Min Jin Go
JLJun Young Lee
Jun Young Lee
SPSuyeon Park
Suyeon Park
SKSoo Heon Kwak
Soo Heon Kwak
BKBong-Jo Kim
Bong-Jo Kim
JLJuyoung Lee
Juyoung Lee

1 July 2021 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
EHEunji Ha
Eunji Ha
SBSo-Young Bang
So-Young Bang
JLJiwoo Lim
Jiwoo Lim
JYJun Ho Yun
Jun Ho Yun
JKJeong-Min Kim
Jeong-Min Kim
SBSuk-Chul Bae
Suk-Chul Bae
Objective CD4+ T cells have been suggested as the most disease-relevant cell type in rheumatoid arthritis (RA) in which RA-risk non-coding variants exhibit allele-specific effects on regulation of RA-driving genes. This study aimed to understand RA-specific signatures in CD4+ T cells using multi-omics data, interpreting inter-omics relationships in shaping the RA transcriptomic landscape. Methods We profiled genome-wide variants, gene expression and DNA methylation in CD4+ T cells from 82 patients with RA and 40 healthy controls using high-throughput technologies. We investigated differentially expressed genes (DEGs) and differential methylated regions (DMRs) in RA and localised quantitative trait loci (QTLs) for expression and methylation. We then integrated these based on individual-level correlations to inspect DEG-regulating sources and investigated the potential regulatory roles of RA-risk variants by a partitioned-heritability enrichment analysis with RA genome-wide association summary statistics. Results A large number of RA-specific DEGs were identified (n=2575), highlighting T cell differentiation and activation pathways. RA-specific DMRs, preferentially located in T cell regulatory regions, were correlated with the expression levels of 548 DEGs mostly in the same topologically associating domains. In addition, expressional variances in 771 and 83 DEGs were partially explained by expression QTLs for DEGs and methylation QTLs (meQTLs) for DEG-correlated DMRs, respectively. A large number of RA variants were moderately to strongly correlated with meQTLs. DEG-correlated DMRs, enriched with meQTLs, had strongly enriched heritability of RA. Conclusion Our findings revealed that the methylomic changes, driven by RA heritability-explaining variants, shape the differential expression of a substantial fraction of DEGs in CD4+ T cells in patients with RA, reinforcing the importance of a multidimensional approach in disease-relevant tissues.